Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Si-Bone Inc (SIBN)

Si-Bone Inc (SIBN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 564,870
  • Shares Outstanding, K 44,165
  • Annual Sales, $ 200,930 K
  • Annual Income, $ -18,900 K
  • EBIT $ -22 M
  • EBITDA $ -19 M
  • 60-Month Beta 0.69
  • Price/Sales 2.81
  • Price/Cash Flow N/A
  • Price/Book 3.12

Options Overview Details

View History
  • Implied Volatility 140.68% (-1.33%)
  • Historical Volatility 35.53%
  • IV Percentile 97%
  • IV Rank 87.30%
  • IV High 154.94% on 03/16/26
  • IV Low 42.57% on 08/14/25
  • Expected Move (DTE 24) 4.04 (31.08%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 10
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 1,077
  • Open Int (30-Day) 1,102
  • Expected Range 8.95 to 17.03

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.18
  • Number of Estimates 3
  • High Estimate -0.16
  • Low Estimate -0.20
  • Prior Year -0.15
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.49 +3.96%
on 03/20/26
16.88 -23.05%
on 02/24/26
-2.63 (-16.84%)
since 02/23/26
3-Month
12.49 +3.96%
on 03/20/26
21.89 -40.66%
on 01/08/26
-7.40 (-36.29%)
since 12/23/25
52-Week
12.49 +3.96%
on 03/20/26
21.89 -40.66%
on 01/08/26
-1.67 (-11.39%)
since 03/21/25

Most Recent Stories

More News
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance

Achieves 20% worldwide revenue growth and positive adjusted EBITDA for Fiscal Year 2025 Generates free cash flow in the Fourth Quarter 2025 SANTA CLARA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- SI-BONE,...

SIBN : 12.99 (+1.56%)
SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026

SANTA CLARA, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone,...

SIBN : 12.99 (+1.56%)
SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026

SANTA CLARA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone,...

SIBN : 12.99 (+1.56%)
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

SANTA CLARA, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone,...

SIBN : 12.99 (+1.56%)
SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025

SANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating...

SIBN : 12.99 (+1.56%)
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance

Delivered ~ 21% worldwide revenue growth, ~ 5% adjusted EBITDA margin, and positive cash from operating activities in the quarter Third Quarter 2025 Financial Highlights (all comparisons are...

SIBN : 12.99 (+1.56%)
SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025

SANTA CLARA, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results...

SIBN : 12.99 (+1.56%)
SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

SANTA CLARA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating...

SIBN : 12.99 (+1.56%)
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance

Second Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $48.6 million, representing growth of 21.7% U.S. revenue of $46.4 million, representing...

SIBN : 12.99 (+1.56%)
SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025

SANTA CLARA, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating...

SIBN : 12.99 (+1.56%)

Business Summary

SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint dysfunction. SI-BONE Inc. is based in Santa Clara, California.

See More

Key Turning Points

3rd Resistance Point 13.86
2nd Resistance Point 13.65
1st Resistance Point 13.32
Last Price 12.99
1st Support Level 12.78
2nd Support Level 12.57
3rd Support Level 12.24

See More

52-Week High 21.89
Fibonacci 61.8% 18.30
Fibonacci 50% 17.19
Fibonacci 38.2% 16.08
Last Price 12.99
52-Week Low 12.49

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.